BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35163489)

  • 1. CD73 and PD-L1 as Potential Therapeutic Targets in Gallbladder Cancer.
    Cao L; Bridle KR; Shrestha R; Prithviraj P; Crawford DHG; Jayachandran A
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NT5E and FcGBP as key regulators of TGF-1-induced epithelial-mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer.
    Xiong L; Wen Y; Miao X; Yang Z
    Cell Tissue Res; 2014 Feb; 355(2):365-74. PubMed ID: 24310606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
    Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
    Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ring finger protein 125, as a potential highly aggressive and unfavorable prognostic biomarker, promotes the invasion and metastasis of human gallbladder cancers via activating the TGF- β1-SMAD3-ID1 signaling pathway.
    Liu ZY; Cao J; Zhang JT; Xu GL; Li XP; Wang FT; Ansari KH; Mohamed H; Fan YZ
    Oncotarget; 2017 Jul; 8(30):49897-49914. PubMed ID: 28611292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A preliminary study of the role of extracellular -5'- nucleotidase in breast cancer stem cells and epithelial-mesenchymal transition.
    Yu J; Liao X; Li L; Lv L; Zhi X; Yu J; Zhou P
    In Vitro Cell Dev Biol Anim; 2017 Feb; 53(2):132-140. PubMed ID: 27670764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells.
    Katsuta E; Tanaka S; Mogushi K; Shimada S; Akiyama Y; Aihara A; Matsumura S; Mitsunori Y; Ban D; Ochiai T; Kudo A; Fukamachi H; Tanaka H; Nakayama K; Arii S; Tanabe M
    Int J Oncol; 2016 Feb; 48(2):657-69. PubMed ID: 26691441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD73 Regulates Stemness and Epithelial-Mesenchymal Transition in Ovarian Cancer-Initiating Cells.
    Lupia M; Angiolini F; Bertalot G; Freddi S; Sachsenmeier KF; Chisci E; Kutryb-Zajac B; Confalonieri S; Smolenski RT; Giovannoni R; Colombo N; Bianchi F; Cavallaro U
    Stem Cell Reports; 2018 Apr; 10(4):1412-1425. PubMed ID: 29551673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway.
    Kong X; Peng H; Liu P; Fu X; Wang N; Zhang D
    Cancer Sci; 2023 Jun; 114(6):2265-2276. PubMed ID: 36751987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral CD73: An immune checkpoint shaping an inhibitory tumor microenvironment and implicating poor prognosis in Chinese melanoma cohorts.
    Gao Z; Wang L; Song Z; Ren M; Yang Y; Li J; Shen K; Li Y; Ding Y; Yang Y; Zhou Y; Wei C; Gu J
    Front Immunol; 2022; 13():954039. PubMed ID: 36131912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual Targeting of Sorafenib-Resistant HCC-Derived Cancer Stem Cells.
    Shrestha R; Bridle KR; Cao L; Crawford DHG; Jayachandran A
    Curr Oncol; 2021 Jun; 28(3):2150-2172. PubMed ID: 34208001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD73 acts as a prognostic biomarker and promotes progression and immune escape in pancreatic cancer.
    Chen Q; Pu N; Yin H; Zhang J; Zhao G; Lou W; Wu W
    J Cell Mol Med; 2020 Aug; 24(15):8674-8686. PubMed ID: 32643277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma.
    Wang N; Xiang X; Chen K; Liu P; Zhu A
    Biochimie; 2018 Mar; 146():56-67. PubMed ID: 29155108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells in immunoregulation and bypassing anti-checkpoint therapy.
    Rouzbahani E; Majidpoor J; Najafi S; Mortezaee K
    Biomed Pharmacother; 2022 Dec; 156():113906. PubMed ID: 36306594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of CD73 expression for the efficacy of immune checkpoint inhibitors in NSCLC.
    Ishii H; Azuma K; Kawahara A; Kinoshita T; Matsuo N; Naito Y; Tokito T; Yamada K; Akiba J; Hoshino T
    Thorac Cancer; 2020 Apr; 11(4):950-955. PubMed ID: 32061060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD73 is associated with poor prognosis in high-grade serous ovarian cancer.
    Turcotte M; Spring K; Pommey S; Chouinard G; Cousineau I; George J; Chen GM; Gendoo DM; Haibe-Kains B; Karn T; Rahimi K; Le Page C; Provencher D; Mes-Masson AM; Stagg J
    Cancer Res; 2015 Nov; 75(21):4494-503. PubMed ID: 26363007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PD-L1 Expression Promotes Epithelial to Mesenchymal Transition in Human Esophageal Cancer.
    Chen L; Xiong Y; Li J; Zheng X; Zhou Q; Turner A; Wu C; Lu B; Jiang J
    Cell Physiol Biochem; 2017; 42(6):2267-2280. PubMed ID: 28848143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GLI2 but not GLI1/GLI3 plays a central role in the induction of malignant phenotype of gallbladder cancer.
    Ichimiya S; Onishi H; Nagao S; Koga S; Sakihama K; Nakayama K; Fujimura A; Oyama Y; Imaizumi A; Oda Y; Nakamura M
    Oncol Rep; 2021 Mar; 45(3):997-1010. PubMed ID: 33650666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune profiling of human tumors identifies CD73 as a combinatorial target in glioblastoma.
    Goswami S; Walle T; Cornish AE; Basu S; Anandhan S; Fernandez I; Vence L; Blando J; Zhao H; Yadav SS; Ott M; Kong LY; Heimberger AB; de Groot J; Sepesi B; Overman M; Kopetz S; Allison JP; Pe'er D; Sharma P
    Nat Med; 2020 Jan; 26(1):39-46. PubMed ID: 31873309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells.
    Fortunato O; Belisario DC; Compagno M; Giovinazzo F; Bracci C; Pastorino U; Horenstein A; Malavasi F; Ferracini R; Scala S; Sozzi G; Roz L; Roato I; Bertolini G
    Front Immunol; 2020; 11():02168. PubMed ID: 33123122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.
    Li H; Liu YT; Chen L; Zhou JJ; Chen DR; Li SJ; Sun ZJ
    Mol Carcinog; 2021 Aug; 60(8):556-566. PubMed ID: 34061408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.